ArticleAmerican heart journal2021

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT).

Henrik Wiggers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.